AEGiS-DMG: Estimated Worldwide HIV Infections: 48713342 At 11.28am On Thursday, September 27, 2002 Daily Mail & GuardianImportant note: Information in this article was accurate in 2002. The state of the art may have changed since the publication date.
Click here to return to Daily Mail & Guardian main menu
DonateNow


Estimated Worldwide HIV Infections: 48713342 At 11.28am On Thursday, September 27, 2002

Mail & Guardian (Johannesburg) - September 27, 2002

Cheaper to treat HIV/Aids: Three million Aids deaths can be averted and more than 2,5-million HIV infections prevented by 2015 through the implementation of voluntary counselling and testing, mother-to-child transmission prevention, improved management of sexually transmitted infections and highly active anti-retroviral therapy, according to a study by the Centre for Actuarial Research. The study says the cost of highly active anti-retroviral therapy (HAART) for adults will gradually increase from R224-million this year to a peak of R18,1-billion in 2015. "With a realistic price reduction in anti-retroviral medicines to R300 a month for a first-line regimen and R450 a month for a second-line regimen, the cost of adult HAART can be reduced to R14,1-billion in 2015."

More money: The South African Aids Vaccine Initiative has announced that the development of three potential HIV vaccines designed in South Africa would receive multimillion-rand support, after showing promise in laboratory testing. These vaccines will soon enter the manufacturing process and safety testing that precedes human clinical trials. The three candidate HIV vaccine products incorporate the genetic sequences of South African strains of HIV (subtype C).

It is hoped they will prove safe and induce immune responses, and eventually show some protective properties in humans.

Sources: The South African Vaccine Initiative and the Treatment Action Campaign\
020927
MG020907

Copyright © 2002 - Daily Mail & Guardian. For information about the content or for permission to redistribute, publish or use for broadcast, contact the publisher.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .